KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Share-based Compensation: 2018-2025

Historic Share-based Compensation for Aurora Cannabis (ACB) over the last 7 years, with Sep 2025 value amounting to $3.6 million.

  • Aurora Cannabis' Share-based Compensation rose 10.21% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year decrease of 4.13%. This contributed to the annual value of $8.0 million for FY2025, which is 14.90% down from last year.
  • Per Aurora Cannabis' latest filing, its Share-based Compensation stood at $3.6 million for Q3 2025, which was up 128.80% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Aurora Cannabis' Share-based Compensation ranged from a high of $4.1 million in Q1 2021 and a low of $1.2 million during Q4 2024.
  • Over the past 3 years, Aurora Cannabis' median Share-based Compensation value was $2.6 million (recorded in 2024), while the average stood at $2.6 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first crashed by 56.07% in 2021, then skyrocketed by 55.22% in 2023.
  • Aurora Cannabis' Share-based Compensation (Quarterly) stood at $3.1 million in 2021, then rose by 1.93% to $3.2 million in 2022, then slumped by 33.88% to $2.1 million in 2023, then tumbled by 43.12% to $1.2 million in 2024, then increased by 10.21% to $3.6 million in 2025.
  • Its Share-based Compensation stands at $3.6 million for Q3 2025, versus $1.6 million for Q2 2025 and $3.8 million for Q1 2025.